$INCY
INCYTE CORP

2020 Q3 Form 10-Q Financial Statement

#000155837020012834 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $620.6M $551.6M $529.9M
YoY Change 12.52% 22.66% 1.61%
Cost Of Revenue $34.32M $30.04M $29.41M
YoY Change 14.25% 21.15% 18.31%
Gross Profit $586.3M $521.5M $500.5M
YoY Change 12.42% 22.75% 0.78%
Gross Profit Margin 94.47% 94.55% 94.45%
Selling, General & Admin $120.8M $102.6M $105.9M
YoY Change 17.72% 6.31% -1.93%
% of Gross Profit 20.6% 19.67% 21.17%
Research & Development $438.1M $281.3M $289.4M
YoY Change 55.72% -3.83% -2.93%
% of Gross Profit 74.72% 53.94% 57.81%
Depreciation & Amortization $12.90M $13.90M $13.40M
YoY Change -7.19% 0.72% -0.74%
% of Gross Profit 2.2% 2.67% 2.68%
Operating Expenses $558.9M $383.9M $395.3M
YoY Change 45.57% -1.31% -2.66%
Operating Profit $5.326M $134.3M $98.61M
YoY Change -96.03% 331.62% 18.47%
Interest Expense $544.0K $597.0K $316.0K
YoY Change -8.88% 47.41% -20.6%
% of Operating Profit 10.21% 0.44% 0.32%
Other Income/Expense, Net $4.917M $11.96M $15.00M
YoY Change -58.89% 17.14% 158.26%
Pretax Income -$3.508M $148.0M $108.7M
YoY Change -102.37% 377.85% 101.21%
Income Tax $11.70M $19.70M $3.400M
% Of Pretax Income 13.31% 3.13%
Net Earnings -$15.20M $128.3M $105.3M
YoY Change -111.85% 339.65% 101.01%
Net Earnings / Revenue -2.45% 23.26% 19.87%
Basic Earnings Per Share -$0.07 $0.60 $0.49
Diluted Earnings Per Share -$0.07 $0.59 $0.48
COMMON SHARES
Basic Shares Outstanding 218.8M 215.2M 214.6M
Diluted Shares Outstanding 218.8M 217.8M 217.5M

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.735B $1.986B $1.696B
YoY Change -12.66% 44.42% 41.51%
Cash & Equivalents $1.498B $1.702B $1.416B
Short-Term Investments $237.0M $284.2M $279.6M
Other Short-Term Assets $51.40M $49.90M $53.60M
YoY Change 3.01% -30.01% -30.84%
Inventory $17.00M $7.400M $6.500M
Prepaid Expenses
Receivables $356.1M $275.5M $302.4M
Other Receivables $100.0K $600.0K $300.0K
Total Short-Term Assets $2.159B $2.320B $2.059B
YoY Change -6.91% 36.41% 28.82%
LONG-TERM ASSETS
Property, Plant & Equipment $498.3M $347.3M $339.1M
YoY Change 43.51% 15.44% 26.73%
Goodwill $155.6M $155.6M $155.6M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $222.8M $117.9M $115.6M
YoY Change 88.97% -2.88% -11.96%
Other Assets $53.11M $38.63M $36.61M
YoY Change 37.49% 83.07% 98.95%
Total Long-Term Assets $1.148B $895.2M $889.0M
YoY Change 28.24% 9.24% 11.25%
TOTAL ASSETS
Total Short-Term Assets $2.159B $2.320B $2.059B
Total Long-Term Assets $1.148B $895.2M $889.0M
Total Assets $3.307B $3.215B $2.948B
YoY Change 2.88% 27.58% 22.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $122.5M $95.38M $66.18M
YoY Change 28.45% -0.13% -12.46%
Accrued Expenses $334.3M $249.7M $210.5M
YoY Change 33.88% -13.8% -17.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $13.90M $800.0K $800.0K
YoY Change 1637.5% -89.47% -89.47%
Total Short-Term Liabilities $606.2M $461.7M $367.1M
YoY Change 31.3% 9.27% -0.3%
LONG-TERM LIABILITIES
Long-Term Debt $32.80M $49.80M $49.50M
YoY Change -34.14% 189.53% 191.18%
Other Long-Term Liabilities $44.60M $33.89M $33.76M
YoY Change 31.59% -87.78% -87.9%
Total Long-Term Liabilities $44.60M $33.89M $33.76M
YoY Change 31.59% -88.49% -88.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $606.2M $461.7M $367.1M
Total Long-Term Liabilities $44.60M $33.89M $33.76M
Total Liabilities $916.6M $792.3M $700.4M
YoY Change 15.69% 10.5% 5.46%
SHAREHOLDERS EQUITY
Retained Earnings -$1.876B -$1.542B -$1.670B
YoY Change 21.7%
Common Stock $4.277B $3.973B $3.926B
YoY Change 7.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.391B $2.423B $2.247B
YoY Change
Total Liabilities & Shareholders Equity $3.307B $3.215B $2.948B
YoY Change 2.88% 27.58% 22.96%

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$15.20M $128.3M $105.3M
YoY Change -111.85% 339.65% 101.01%
Depreciation, Depletion And Amortization $12.90M $13.90M $13.40M
YoY Change -7.19% 0.72% -0.74%
Cash From Operating Activities $182.1M $270.4M $152.9M
YoY Change -32.66% 35.74% 371.91%
INVESTING ACTIVITIES
Capital Expenditures -$52.80M $16.90M -$47.30M
YoY Change -412.43% -168.15% 337.96%
Acquisitions
YoY Change
Other Investing Activities $38.40M -$4.600M $2.200M
YoY Change -934.78% -165.71% -67.65%
Cash From Investing Activities -$14.50M $12.30M -$45.10M
YoY Change -217.89% -169.1% 1027.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 900.0K 2.900M 9.000M
YoY Change -68.97% 20.83% 60.71%
NET CHANGE
Cash From Operating Activities 182.1M 270.4M 152.9M
Cash From Investing Activities -14.50M 12.30M -45.10M
Cash From Financing Activities 900.0K 2.900M 9.000M
Net Change In Cash 168.5M 285.6M 116.8M
YoY Change -41.0% 55.39% 243.53%
FREE CASH FLOW
Cash From Operating Activities $182.1M $270.4M $152.9M
Capital Expenditures -$52.80M $16.90M -$47.30M
Free Cash Flow $234.9M $253.5M $200.2M
YoY Change -7.34% 13.17% 363.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
216177830
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
218903097
CY2020Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2019Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2020Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:FinanceLeaseLiabilityCurrent
CY2019Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:FinanceLeaseLiabilityCurrent
CY2020Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2019Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2020Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:FinanceLeaseLiabilityNoncurrent
CY2019Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:FinanceLeaseLiabilityNoncurrent
us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
us-gaap:OtherNonoperatingIncomeExpense
CY2019Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
us-gaap:OtherNonoperatingIncomeExpense
us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
us-gaap:OtherNonoperatingIncomeExpense
CY2020Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
us-gaap:OtherNonoperatingIncomeExpense
dei Entity Registrant Name
EntityRegistrantName
INCYTE CORP
dei Entity Central Index Key
EntityCentralIndexKey
0000879169
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-12400
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3136539
dei Entity Address Address Line1
EntityAddressAddressLine1
1801 Augustine Cut-Off
dei Entity Address City Or Town
EntityAddressCityOrTown
Wilmington
dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19803
dei City Area Code
CityAreaCode
302
dei Local Phone Number
LocalPhoneNumber
498-6700
dei Security12b Title
Security12bTitle
Common Stock, $.001 par value per share
dei Trading Symbol
TradingSymbol
INCY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
218996090
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1497775000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1832684000
CY2020Q3 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
236902000
CY2020Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
237025000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
284870000
CY2020Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
356182000
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
308809000
CY2020Q3 us-gaap Inventory Net
InventoryNet
17012000
CY2019Q4 us-gaap Inventory Net
InventoryNet
11400000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
51431000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43725000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
2159425000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
2481488000
CY2020Q3 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
2663000
CY2019Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1023000
CY2020Q3 us-gaap Long Term Investments
LongTermInvestments
222810000
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
133657000
CY2020Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
8697000
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
5105000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
498335000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
377567000
CY2020Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
29123000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
29058000
CY2020Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
177675000
CY2019Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
193828000
CY2020Q3 us-gaap Goodwill
Goodwill
155593000
CY2019Q4 us-gaap Goodwill
Goodwill
155593000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53109000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49431000
CY2020Q3 us-gaap Assets
Assets
3307430000
CY2019Q4 us-gaap Assets
Assets
3426750000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
122512000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
83647000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
96391000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
90706000
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
56000
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
29000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
334315000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
285950000
CY2020Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1978000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
664000
CY2020Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
11900000
CY2019Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
18300000
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
39050000
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
34044000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
606202000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
513340000
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
232950000
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
242956000
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
32848000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
31918000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
44597000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
40130000
CY2020Q3 us-gaap Liabilities
Liabilities
916597000
CY2019Q4 us-gaap Liabilities
Liabilities
828344000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
218903097
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
216177830
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
219000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
216000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4276667000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4044490000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9748000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-15542000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1876305000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1430758000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
2390833000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2598406000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3307430000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3426750000
CY2020Q3 us-gaap Revenues
Revenues
620643000
CY2019Q3 us-gaap Revenues
Revenues
551581000
us-gaap Revenues
Revenues
1877193000
us-gaap Revenues
Revenues
1579370000
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
34322000
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
30040000
us-gaap Cost Of Revenue
CostOfRevenue
95005000
us-gaap Cost Of Revenue
CostOfRevenue
82034000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
438109000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
281336000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1809997000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
841244000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
120788000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
102608000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
349934000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
332534000
CY2020Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
7109000
CY2019Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
3281000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
19790000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
16560000
CY2020Q3 incy Collaboration Loss Sharing Expense
CollaborationLossSharingExpense
14989000
incy Collaboration Loss Sharing Expense
CollaborationLossSharingExpense
30372000
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
615317000
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
417265000
us-gaap Costs And Expenses
CostsAndExpenses
2305098000
us-gaap Costs And Expenses
CostsAndExpenses
1272372000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
5326000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
134316000
CY2020Q3 us-gaap Interest Expense
InterestExpense
544000
CY2019Q3 us-gaap Interest Expense
InterestExpense
597000
us-gaap Interest Expense
InterestExpense
1746000
us-gaap Interest Expense
InterestExpense
1248000
CY2020Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-13207000
CY2019Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
2339000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24886000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15203000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
128271000
us-gaap Net Income Loss
NetIncomeLoss
-445547000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
10935000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
18703000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3508000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
148019000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-400320000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
360787000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11695000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19748000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45227000
us-gaap Operating Income Loss
OperatingIncomeLoss
-427905000
us-gaap Operating Income Loss
OperatingIncomeLoss
306998000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4917000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11961000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18396000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
36334000
us-gaap Net Income Loss
NetIncomeLoss
335901000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.57
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.55
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218784000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
215199000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217684000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214628000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218784000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217791000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217684000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217393000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15203000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
128271000
us-gaap Net Income Loss
NetIncomeLoss
-445547000
us-gaap Net Income Loss
NetIncomeLoss
335901000
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2532000
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
187000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
5085000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
29000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-77000
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
36000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
48000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1175000
CY2020Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-220000
CY2019Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-128000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-661000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-347000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2675000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
351000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5794000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1551000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12528000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
128622000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-439753000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
337452000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2598406000
CY2020Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
772538
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14619000
CY2020Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1957
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
145000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
42758000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2435000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-720642000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1937721000
CY2020Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
936688
CY2020Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
175615
CY2020Q2 incy Stock Issued During Period Value Stock Options And Restricted Stock Units Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsExercisedAndEmployeeStockPurchasePlan
69194000
CY2020Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1403
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
139000
CY2020Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
3187
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
162000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46406000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
684000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
290298000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2344604000
CY2020Q3 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
698032
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7783000
CY2020Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1434
CY2020Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
131000
CY2020Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
134413
CY2020Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
6873000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
43970000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2675000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15203000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
2390833000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1925967000
CY2019Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
1044745
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15481000
CY2019Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1200
CY2019Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
104000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40690000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
918000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
102312000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
2085567000
CY2019Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
400292
CY2019Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
143379
CY2019Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
129000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
43474000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
351000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
128271000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
2422527000
us-gaap Profit Loss
ProfitLoss
-445547000
us-gaap Profit Loss
ProfitLoss
335901000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38641000
CY2019Q2 incy Stock Issued During Period Value Stock Options And Restricted Stock Units Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsExercisedAndEmployeeStockPurchasePlan
15191000
CY2019Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1444
CY2019Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
123000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40710000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
282000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
105318000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
2247191000
CY2019Q3 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
506199
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3111000
CY2019Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1629
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41188000
us-gaap Share Based Compensation
ShareBasedCompensation
132616000
us-gaap Share Based Compensation
ShareBasedCompensation
124566000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-8698000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-356000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
10935000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
18703000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
19790000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
16560000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
55656000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-31482000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11384000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-9999000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9204000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2913000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
38865000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8451000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
62196000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
49053000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-231920000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
135946000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
48749000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
418698000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
579038000
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
95468000
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
17250000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
222157000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
466591000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
213480000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-166271000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57426000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
91596000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
33783000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
619000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
626000
incy Payment Of Contingent Consideration
PaymentOfContingentConsideration
31140000
incy Payment Of Contingent Consideration
PaymentOfContingentConsideration
16766000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59837000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16391000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5085000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-333269000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
538032000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1833707000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1164986000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1500438000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1703018000
us-gaap Interest Paid Net
InterestPaidNet
119000
us-gaap Interest Paid Net
InterestPaidNet
119000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
56757000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12398000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
6992000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
12836000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13020000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6686000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
2160000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
29740000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Use of Estimates.</i>  The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
CY2020Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1978000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><i style="font-style:italic;">Concentrations of Credit Risk.</i>  Cash, cash equivalents, marketable securities, and trade receivables are financial instruments which potentially subject us to concentrations of credit risk. The estimated fair value of financial instruments approximates the carrying value based on available market information. We primarily invest our excess available funds in </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">debt securities and, by policy, limit the amount of credit exposure to any one issuer and to any one type of investment, other than securities issued or guaranteed by the U.S. government and money market funds that meet certain guidelines. Our receivables mainly relate to our product sales and collaborative agreements with pharmaceutical companies. We have not experienced any significant credit losses on cash, cash equivalents, marketable securities, or trade receivables to date and do not require collateral on receivables.</p>
incy Credit Exposure Limitation Number Of Issuer Other Than United States Government Guaranteed Securities
CreditExposureLimitationNumberOfIssuerOtherThanUnitedStatesGovernmentGuaranteedSecurities
1
incy Credit Exposure Limitation Number Of Financial Investment Other Than United States Government Guaranteed Securities
CreditExposureLimitationNumberOfFinancialInvestmentOtherThanUnitedStatesGovernmentGuaranteedSecurities
1
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
600000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
600000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
132600000
CY2020Q3 incy Variable Interest Entities Number
VariableInterestEntitiesNumber
0
incy Percentage Of Medicare Part D Insurance Coverage Gap Required To Be Funded By Manufacturers
PercentageOfMedicarePartDInsuranceCoverageGapRequiredToBeFundedByManufacturers
0.70
incy Medicare Part D Insurance Coverage Gap Increase In Eligible Patient Spending Percentage
MedicarePartDInsuranceCoverageGapIncreaseInEligiblePatientSpendingPercentage
0.30
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
620643000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
551581000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1877193000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1579370000
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1275000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1275000
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
9745000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8634000
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14689000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6596000
CY2020Q3 incy Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
25709000
CY2019Q4 incy Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
16505000
CY2020Q3 us-gaap Inventory Net
InventoryNet
17012000
CY2019Q4 us-gaap Inventory Net
InventoryNet
11400000
CY2020Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
8697000
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
5105000
CY2020Q3 us-gaap Inventory Net
InventoryNet
17000000.0
CY2020Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
8700000
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
635483000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
499437000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
137148000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
121870000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
498335000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
377567000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
664000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13424000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11854000
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
32848000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
31918000
CY2020Q3 incy Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
58963000
CY2019Q4 incy Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
53779000
us-gaap Operating Lease Payments
OperatingLeasePayments
8700000
us-gaap Operating Lease Payments
OperatingLeasePayments
8600000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10713000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9343000
us-gaap Lessee Operating Lease Existence Of Residual Value Guarantee
LesseeOperatingLeaseExistenceOfResidualValueGuarantee
false
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P14Y10M24D
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M24D
CY2020Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.036
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2900000
us-gaap Operating Lease Cost
OperatingLeaseCost
9000000.0
CY2020Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
700000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1900000
CY2020Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
300000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
900000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3600000
us-gaap Operating Lease Cost
OperatingLeaseCost
10900000
CY2019Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
700000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1100000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
300000
CY2019Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
300000
CY2020Q3 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
73610000
CY2019Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
59924000
CY2020Q3 us-gaap Construction Payable Current
ConstructionPayableCurrent
12835000
CY2019Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
12732000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10713000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9343000
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
49557000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
21536000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
21536000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
86147000
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
43800000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5384000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
21536000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
21536000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
43400000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
124600000
CY2020Q3 incy Stock Compensation Expense Capitalized
StockCompensationExpenseCapitalized
200000
incy Stock Compensation Expense Capitalized
StockCompensationExpenseCapitalized
500000
CY2019Q3 incy Stock Compensation Expense Capitalized
StockCompensationExpenseCapitalized
100000
incy Stock Compensation Expense Capitalized
StockCompensationExpenseCapitalized
300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed
Black-Scholes valuation model
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2602376
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
79.69
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
3167196
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
87.45
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
9882122
incy Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesGranted
4755820
incy Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Canceled
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesCanceled
641542
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5767844
incy Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Annualized Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedAnnualizedForfeitureRate
0.05
CY2020Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
92149000
CY2019Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
73221000
CY2020Q3 incy Accrued Clinical Related Costs Current
AccruedClinicalRelatedCostsCurrent
95451000
CY2019Q4 incy Accrued Clinical Related Costs Current
AccruedClinicalRelatedCostsCurrent
88710000
CY2019Q3 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-74000
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-500000
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-186000
CY2020Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1760000
CY2019Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1415000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
10100000
CY2019Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3000000.0
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
9000000.0
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
42020000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
334315000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
285950000
CY2020Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3500000
CY2020Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1523000
CY2019Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1263000
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
4457000
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
3813000
CY2020Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
49000
CY2019Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
84000
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
142000
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
253000
CY2020Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
32000
CY2019Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
60000
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
93000
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
180000
CY2020Q3 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
54000
CY2019Q3 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
54000
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
161000
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
161000
CY2020Q3 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-166000
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
5167000
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
4233000
CY2020Q3 us-gaap Defined Benefit Plan Expected Future Employer Contributions Current Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear
4000000.0
CY2020Q3 us-gaap Defined Benefit Pension Plan Current And Noncurrent Liabilities
DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
26200000
CY2019Q4 us-gaap Defined Benefit Pension Plan Current And Noncurrent Liabilities
DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
24100000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11700000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45200000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19700000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24900000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
1500000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-100000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15203000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
128271000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-445547000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
335901000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218784000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
215199000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217684000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214628000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.57
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-15203000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
128271000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-445547000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
335901000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218784000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
215199000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217684000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214628000
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2592000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2765000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218784000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217791000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217684000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217393000
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.55
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15678728
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9262535
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15678728
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9826380

Files In Submission

Name View Source Status
0001558370-20-012834-index-headers.html Edgar Link pending
0001558370-20-012834-index.html Edgar Link pending
0001558370-20-012834.txt Edgar Link pending
0001558370-20-012834-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
incy-20200930.xsd Edgar Link pending
incy-20200930x10q.htm Edgar Link pending
incy-20200930x10q_htm.xml Edgar Link completed
incy-20200930xex10d1.htm Edgar Link pending
incy-20200930xex10d2.htm Edgar Link pending
incy-20200930xex10d3.htm Edgar Link pending
incy-20200930xex31d1.htm Edgar Link pending
incy-20200930xex31d2.htm Edgar Link pending
incy-20200930xex32d1.htm Edgar Link pending
incy-20200930xex32d2.htm Edgar Link pending
incy-20200930_cal.xml Edgar Link unprocessable
incy-20200930_def.xml Edgar Link unprocessable
incy-20200930_lab.xml Edgar Link unprocessable
incy-20200930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending